| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
15,080,000 |
| Market
Cap: |
23.07(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.39 - $2.3 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cumberland Pharmaceuticals is a pharmaceutical company engaged on the acquisition, development and commercialization of prescription products. Co.'s portfolio of brands include: Acetadote® (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor® (ibuprofen) injection, for the treatment of pain and fever; Kristalose® (lactulose) for the treatment of constipation; Omeclamox®-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori infection and related duodenal ulcer disease; and Vaprisol® (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
19,901 |
| Total Buy Value |
$0 |
$0 |
$0 |
$47,759 |
| Total People Bought |
0 |
0 |
0 |
4 |
| Total Buy Transactions |
0 |
0 |
0 |
332 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Krogulski Kenneth |
Director |
– • – |
2022-08-10 |
4 |
AB |
$2.19 |
$302 |
D/D |
138 |
193,514 |
|
-11% |
|
| Jones James |
Director |
– • – |
2022-08-10 |
4 |
AB |
$2.19 |
$88 |
D/D |
40 |
23,143 |
|
-11% |
|
| Galante Joseph C |
Director |
– • – |
2022-08-10 |
4 |
AB |
$2.19 |
$180 |
D/D |
82 |
50,662 |
|
-11% |
|
| Young Caroline |
Director |
– • – |
2022-08-09 |
4 |
AB |
$2.19 |
$57 |
D/D |
26 |
17,584 |
|
3% |
|
| Krogulski Kenneth |
Director |
– • – |
2022-08-09 |
4 |
AB |
$2.19 |
$302 |
D/D |
138 |
193,376 |
|
3% |
|
| Jones James |
Director |
– • – |
2022-08-09 |
4 |
AB |
$2.19 |
$88 |
D/D |
40 |
23,103 |
|
3% |
|
| Galante Joseph C |
Director |
– • – |
2022-08-09 |
4 |
AB |
$2.19 |
$180 |
D/D |
82 |
50,580 |
|
3% |
|
| Young Caroline |
Director |
– • – |
2022-08-08 |
4 |
AB |
$2.19 |
$57 |
D/D |
26 |
17,558 |
|
0% |
|
| Krogulski Kenneth |
Director |
– • – |
2022-08-08 |
4 |
AB |
$2.19 |
$302 |
D/D |
138 |
193,238 |
|
0% |
|
| Jones James |
Director |
– • – |
2022-08-08 |
4 |
AB |
$2.19 |
$88 |
D/D |
40 |
23,063 |
|
0% |
|
| Galante Joseph C |
Director |
– • – |
2022-08-08 |
4 |
AB |
$2.19 |
$180 |
D/D |
82 |
50,498 |
|
0% |
|
| Young Caroline |
Director |
– • – |
2022-08-05 |
4 |
AB |
$2.12 |
$51 |
D/D |
24 |
17,532 |
|
9% |
|
| Krogulski Kenneth |
Director |
– • – |
2022-08-05 |
4 |
AB |
$2.12 |
$263 |
D/D |
124 |
193,100 |
|
9% |
|
| Jones James |
Director |
– • – |
2022-08-05 |
4 |
AB |
$2.12 |
$78 |
D/D |
37 |
23,023 |
|
9% |
|
| Galante Joseph C |
Director |
– • – |
2022-08-05 |
4 |
AB |
$2.12 |
$157 |
D/D |
74 |
50,416 |
|
9% |
|
| Young Caroline |
Director |
– • – |
2022-08-04 |
4 |
AB |
$2.17 |
$52 |
D/D |
24 |
17,508 |
|
5% |
|
| Krogulski Kenneth |
Director |
– • – |
2022-08-04 |
4 |
AB |
$2.17 |
$269 |
D/D |
124 |
192,976 |
|
5% |
|
| Jones James |
Director |
– • – |
2022-08-04 |
4 |
AB |
$2.17 |
$80 |
D/D |
37 |
22,986 |
|
5% |
|
| Galante Joseph C |
Director |
– • – |
2022-08-04 |
4 |
AB |
$2.17 |
$161 |
D/D |
74 |
50,342 |
|
5% |
|
| Young Caroline |
Director |
– • – |
2022-08-03 |
4 |
AB |
$2.45 |
$29 |
D/D |
12 |
17,484 |
|
1% |
|
| Krogulski Kenneth |
Director |
– • – |
2022-08-03 |
4 |
AB |
$2.45 |
$123 |
D/D |
50 |
192,852 |
|
1% |
|
| Jones James |
Director |
– • – |
2022-08-03 |
4 |
AB |
$2.45 |
$49 |
D/D |
20 |
22,949 |
|
1% |
|
| Galante Joseph C |
Director |
– • – |
2022-08-03 |
4 |
AB |
$2.45 |
$74 |
D/D |
30 |
50,268 |
|
1% |
|
| Young Caroline |
Director |
– • – |
2022-08-01 |
4 |
AB |
$2.34 |
$56 |
D/D |
24 |
17,472 |
|
-7% |
|
| Krogulski Kenneth |
Director |
– • – |
2022-08-01 |
4 |
AB |
$2.34 |
$290 |
D/D |
124 |
192,802 |
|
-7% |
|
2379 Records found
|
|
Page 22 of 96 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.01 (0.66%) 
